Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-25 Sale |
2025-02-27 5:00 pm |
Cullinan Therapeutics Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
3,756 | $8.53 | $32,039 | 136,895 (Direct) |
View |
| 2024-12-18 Sale |
2024-12-20 5:00 pm |
Cullinan Therapeutics Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
3,482 | $11.41 | $39,730 | 90,651 (Direct) |
View |
| 2023-12-21 Sale |
2023-12-22 5:30 pm |
Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
1,400 | $8.5 | $11,900 | 44,133 (Direct) |
View |
| 2023-12-18 Sale |
2023-12-20 6:00 pm |
Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
290 | $8.22 | $2,384 | 45,533 (Direct) |
View |
| 2023-06-20 Sale |
2023-06-21 4:17 pm |
Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
291 | $12.94 | $3,766 | 45,823 (Direct) |
View |
| 2023-05-18 Sale |
2023-05-19 4:45 pm |
Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
291 | $8.76 | $2,549 | 46,114 (Direct) |
View |
| 2023-04-18 Sale |
2023-04-20 4:30 pm |
Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
290 | $10.71 | $3,106 | 46,405 (Direct) |
View |
| 2023-03-20 Sale |
2023-03-27 4:05 pm |
Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
305 | $11.32 | $3,453 | 46,695 (Direct) |
View |
| 2022-06-01 Sale |
2022-06-02 4:32 pm |
GENOCEA BIOSCIENCES INC. | GNCA | SUMER JACQUELYN L CHIEF LEGAL & COMPLIANCE OFF |
2,500 | $0.0601 | $150 | 43,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-19 Option Award |
2025-02-21 6:00 pm |
N/A 2035-02-19 |
Cullinan Therapeutics Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
150,000 | $0 | 240,651 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-23 5:00 pm |
N/A 2034-02-22 |
Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
150,000 | $0 | 194,133 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 6:54 pm |
N/A 2033-02-16 |
Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
140,500 | $0 | 140,500 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-16 5:07 pm |
N/A 2032-08-14 |
Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
190,000 | $0 | 190,000 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 4:17 pm |
N/A 2022-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | SUMER JACQUELYN L CHIEF LEGAL & COMPLIANCE OFF |
150,000 | $0 | 158,000 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 1:48 pm |
N/A N/A |
GENOCEA BIOSCIENCES INC. | GNCA | SUMER JACQUELYN L CHIEF LEGAL & COMPLIANCE OFF |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-02 09:11 am |
N/A 2031-03-01 |
GENOCEA BIOSCIENCES INC. | GNCA | SUMER JACQUELYN L CHIEF LEGAL & COMPLIANCE OFF |
115,000 | $3.07 | 115,000 (Direct) |
View |
Ownership |
2021-02-23 1:45 pm |
N/A N/A |
GENOCEA BIOSCIENCES INC. | GNCA | SUMER JACQUELYN L CHIEF LEGAL & COMPLIANCE OFF |
0 | $0 | 5,500 (Direct) |
View |